Phathom Pharmaceuticals, Inc.PHATNASDAQ

Revenue (LTM)

$175M

+216.9% YoY

Net Income (LTM)

$-221M

+33.8% YoY

Free Cash Flow

$-167M

Revenue CAGR (5Y)

—

Marginsimproving

FCF($0.2B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	0	0	1	55↑8001.5%	175↑216.9%
Gross Profit	-1	-1↓19.0%	1↑183.1%	47↑9080.4%	153↑222.6%
Operating Income	-135	-172↓27.7%	-167↑3.0%	-277↓65.8%	-160↑42.3%
Net Income	-144	-198↓37.4%	-202↓2.0%	-334↓65.8%	-221↑33.8%
EBITDA	-137	-170↓24.3%	-159↑6.3%	-262↓64.4%	-152↑41.7%
EPS Diluted	-4.00	-5.70↓42.5%	-3.93↑31.1%	-5.29↓34.6%	-3.03↑42.7%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	183	155↓15.2%	381↑145.5%	297↓22.1%	130↓56.3%
Total Current Assets	187	161↓13.9%	397↑147.6%	360↓9.4%	229↓36.4%
Total Assets	189	165↓13.0%	414↑151.1%	378↓8.6%	259↓31.5%
Total Current Liabilities	19	26↑38.7%	39↑47.8%	86↑121.1%	132↑54.0%
Total Liabilities	117	240↑104.3%	487↑103.1%	632↑29.9%	697↑10.4%
Total Equity	72	-75↓203.7%	-73↑2.7%	-254↓248.5%	-438↓72.8%
Total Debt	91	97↑6.3%	139↑43.2%	555↑299.2%	3↓99.5%
Net Debt	-92	-58↑36.6%	-242↓315.6%	258↑206.3%	-127↓149.4%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-148	-147↑1.3%	-138↑6.1%	-267↓93.9%	-167↑37.5%
Capital Expenditure	-0	-1↓217.4%	-2↓57.0%	-0↑91.7%	-0↓69.6%
Free Cash Flow	-149	-148↑0.8%	-139↑5.7%	-267↓91.7%	-167↑37.5%
Stock-Based Comp	17	24↑43.5%	45↑86.6%	24↓46.6%	29↑19.4%
Net Change in Cash	-104	-28↑73.2%	228↑919.3%	-84↓136.8%	-167↓98.8%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance